Results 171 to 180 of about 1,208,213 (298)

Exploring the exploration: implications of leaving or remaining at the natal site during the early stages of independence in a partially migratory bird

open access: yesIbis, EarlyView.
Despite being an important fraction of any animal population, juveniles are a severely understudied group. Juveniles often need to learn an array of skills that allow them to survive independently and do so while undertaking decisions that may impact their fitness, recruitment and survival, having therefore relevant demographic implications.
Manuela S. Rodrigues   +6 more
wiley   +1 more source

Delphi consensus: First‐line use of biologics and small molecules in hidradenitis suppurativa

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
This Delphi Consensus study identified upgrade criteria for the use of biologics and small molecules as first‐line therapy in hidradenitis suppurativa (HS). European HS experts evaluated 16 clinical scenarios, voting on eligibility for therapy escalation.
Georgios Nikolakis   +54 more
wiley   +1 more source

[Health workers exposed to pesticides: a cross-sectional study involving agents for the control of endemic diseases in the State of Rio de Janeiro, Brazil]. [PDF]

open access: yesCad Saude Publica
Vidal PJDSR   +7 more
europepmc   +1 more source

Long‐term efficacy of biologics in moderate‐to‐severe hidradenitis suppurativa: A systematic review and MAIC

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
A matching‐adjusted indirect treatment comparison (MAIC) was conducted, comparing approved biologics for long‐term (48–52 weeks) treatment of moderate‐to‐severe hidradenitis suppurativa (HS). Using weighted patient‐level trial data allowed re‐estimation of relative bimekizumab efficacy compared with aggregate secukinumab and adalimumab trial data ...
Thrasyvoulos Tzellos   +9 more
wiley   +1 more source

Bimekizumab efficacy using IHS4 outcomes in hidradenitis suppurativa: Results from BE HEARD I and II

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
The majority of bimekizumab‐treated patients shifted from severe to mild and moderate IHS4 stages, and nearly 25% achieved an IHS4 of 0 by Week 48. Bimekizumab led to clinically meaningful improvements across IHS4 outcome measures. These data highlight an opportunity to address the need for effective treatments against draining tunnels.
Thrasyvoulos Tzellos   +15 more
wiley   +1 more source

Systemic effects of sunlight: 10‐year review of cardiovascular, infection and cancer outcomes

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
This review highlights the systemic effects of sunlight and ultraviolet radiation. While UV radiation exposure has known cutaneous risks including photoaging and skin cancer, evidence suggests potential associations with reduced all‐cause mortality, improved infectious disease outcomes and reduced blood pressure.
Jasira A. Ziglar   +5 more
wiley   +1 more source

Diagnostic performance of donor-derived cell-free DNA for acute rejection in kidney allograft biopsies. [PDF]

open access: yesJ Bras Nefrol
Nakamura MR   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy